Physician profile
Wendell Ms Moses
NPI 1760462261
$1,016.21
in general payments reported to CMS, 2019-2025
16 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $24.68 · 2022: $23.44 · 2023: $169 · 2024: $331 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $842.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $191.84 | 2019-2024 | Real Intelligence, Synergy |
| Smoky Mountain Surgical LLC | $134.98 | 2023-2025 | |
| Innovation Technologies INC | $113.76 | 2025 | Irrisept |
| Depuy Synthes Sales INC. | $96.95 | 2019-2023 | Expedium Verse |
| Lifenet Health | $95.86 | 2024 | Allograft Vmis Delivery System |
| Acera Surgical, INC. | $78.38 | 2025 | Restrata Wound Matrix |
| Access Pro Medical, LLC | $53.55 | 2025 | Matriderm |
| Ipsen Biopharmaceuticals, INC | $41.27 | 2023-2024 | Sohonos |
| Globus Medical, INC. | $32.58 | 2023 | Mini Fragment System |
| Orthopediatrics Corp. | $32.23 | 2025 | |
| Biomarin Pharmaceutical INC. | $31.10 | 2020-2025 | Voxzogo 1.2mg |
| Ultragenyx Pharmaceutical INC. | $26.63 | 2023 | |
| Misonix INC | $24.83 | 2019 | |
| Kyowa Kirin, INC. | $24.12 | 2024 | Crysvita |
| Pacira Pharmaceuticals Incorporated | $23.44 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $14.69 | 2025 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendell Moses listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.